Correlation Between 4D Molecular and Corbus Pharmaceuticals
Can any of the company-specific risk be diversified away by investing in both 4D Molecular and Corbus Pharmaceuticals at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining 4D Molecular and Corbus Pharmaceuticals into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between 4D Molecular Therapeutics and Corbus Pharmaceuticals Holding, you can compare the effects of market volatilities on 4D Molecular and Corbus Pharmaceuticals and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in 4D Molecular with a short position of Corbus Pharmaceuticals. Check out your portfolio center. Please also check ongoing floating volatility patterns of 4D Molecular and Corbus Pharmaceuticals.
Diversification Opportunities for 4D Molecular and Corbus Pharmaceuticals
0.94 | Correlation Coefficient |
Almost no diversification
The 3 months correlation between FDMT and Corbus is 0.94. Overlapping area represents the amount of risk that can be diversified away by holding 4D Molecular Therapeutics and Corbus Pharmaceuticals Holding in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Corbus Pharmaceuticals and 4D Molecular is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on 4D Molecular Therapeutics are associated (or correlated) with Corbus Pharmaceuticals. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Corbus Pharmaceuticals has no effect on the direction of 4D Molecular i.e., 4D Molecular and Corbus Pharmaceuticals go up and down completely randomly.
Pair Corralation between 4D Molecular and Corbus Pharmaceuticals
Given the investment horizon of 90 days 4D Molecular Therapeutics is expected to under-perform the Corbus Pharmaceuticals. But the stock apears to be less risky and, when comparing its historical volatility, 4D Molecular Therapeutics is 1.4 times less risky than Corbus Pharmaceuticals. The stock trades about -0.11 of its potential returns per unit of risk. The Corbus Pharmaceuticals Holding is currently generating about -0.01 of returns per unit of risk over similar time horizon. If you would invest 3,460 in Corbus Pharmaceuticals Holding on September 1, 2024 and sell it today you would lose (1,696) from holding Corbus Pharmaceuticals Holding or give up 49.02% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Strong |
| Accuracy | 100.0% |
| Values | Daily Returns |
4D Molecular Therapeutics vs. Corbus Pharmaceuticals Holding
Performance |
| Timeline |
| 4D Molecular Therapeutics |
| Corbus Pharmaceuticals |
4D Molecular and Corbus Pharmaceuticals Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with 4D Molecular and Corbus Pharmaceuticals
The main advantage of trading using opposite 4D Molecular and Corbus Pharmaceuticals positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if 4D Molecular position performs unexpectedly, Corbus Pharmaceuticals can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Corbus Pharmaceuticals will offset losses from the drop in Corbus Pharmaceuticals' long position.| 4D Molecular vs. Tff Pharmaceuticals | 4D Molecular vs. Eliem Therapeutics | 4D Molecular vs. Inhibrx | 4D Molecular vs. Enliven Therapeutics |
| Corbus Pharmaceuticals vs. Trevi Therapeutics | Corbus Pharmaceuticals vs. Cue Biopharma | Corbus Pharmaceuticals vs. AN2 Therapeutics | Corbus Pharmaceuticals vs. Bioatla |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios | |
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |